ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,865Medicare Part D Prescriptions Filled, Including Refills
$578K Total Retail Price of All Prescriptions
307 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 297 227
METFORMIN HCL 216 138
LANTUS SOLOSTAR 187 130
LISINOPRIL 169 117
LEVOTHYROXINE SODIUM 161 141
NOVOLOG FLEXPEN 146 92
OMEPRAZOLE 138 97
PEN NEEDLE 130 70
AMLODIPINE BESYLATE 119 98
ATORVASTATIN CALCIUM 111 97
HYDROCHLOROTHIAZIDE 108 69
JANUVIA 102 102
METOPROLOL TARTRATE 99 91
ISOSORBIDE MONONITRATE ER 98 98
ACTOS 94 92
SYNTHROID 92 52
ZOLPIDEM TARTRATE 92 84
TRAMADOL HCL 86 40
GLIMEPIRIDE 86 50
FUROSEMIDE 82 79
GABAPENTIN 82 58
ALENDRONATE SODIUM 77 74
INSULIN SYRINGE 71 47
TAMSULOSIN HCL 68 53
POTASSIUM CHLORIDE 66 44
ATENOLOL 65 54
ENALAPRIL MALEATE 65 65
LANTUS 64 38
OXYCODONE HCL-ACETAMINOPHEN 60 37 S2
SERTRALINE HCL 59 25
METHIMAZOLE 57 54
PREDNISONE 53 42
HUMALOG 52 23
HYDROCODONE-ACETAMINOPHEN 51 31 S3
PIOGLITAZONE HCL 50 47 R
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.